FLUDARABINE Safety Questions, FLUDARABINE Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about FLUDARABINE. Our extensive database of FLUDARABINE adverse events and FLUDARABINE warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about FLUDARABINE

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




FLUDARABINE Safety Reports

Total FLUDARABINE reports: 160.
FLUDARABINE FDA safety alerts: No.
Reported deaths: 41    Reported hospitalizations: 87.
Take FLUDARABINE Side Effects Survey or Share Your FLUDARABINE Story. Read More Here.

Showing 1-75 of 160 Next >

Health Professional from UNITED STATES reported FLUDARABINE problem on Aug 11, 2006. Male patient, weighting 104.1 lb, was diagnosed with stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: bacterial infection, blood pressure decreased, body temperature increased, chronic obstructive pulmonary disease, hypoventilation, loss of consciousness, lung hyperinflation, staphylococcal infection. FLUDARABINE dosage: 48 MG DAILY IV DRIP. During the same period patient was treated with CAMPATH, BUSULFAN, PROGRAF, PREVACID, ZOFRAN, AVELOX, VOIROCNAZOLES, IMIPENEN. Patient was hospitalized. Patient recovered.

FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Aug 11, 2006. Female patient, weighting 154.3 lb, was diagnosed with stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: respiratory distress. FLUDARABINE dosage: 45 MG DAILY IV DRIP. During the same period patient was treated with MELPHALAN, CAMPATH. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from AUSTRALIA reported FLUDARABINE problem on July 26, 2006. Male patient, 45 years of age, weighting 183.9 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: migraine. FLUDARABINE dosage: 47.5 MG/DAY, 5 CYCLES X 3 DAYS, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, METOCLOPRAMIDE, CYCLIZINE, DOLASETRON, PANADENE. Patient recovered.

FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Aug 17, 2006. Male patient, 58 years of age, was diagnosed with chronic lymphocytic leukaemia transformation and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: retinal haemorrhage. FLUDARABINE dosage: 30 MG/M2, DAYS 2-3. During the same period patient was treated with CYTARABINE, RITUXAN, OXALIPLATIN, COMPAZINE, DARVON, PROTONIX, HUMULIN, VALTREX. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported FLUDARABINE problem on Aug 21, 2006. Male patient, weighting 169.8 lb, was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: anaemia, chest x-ray abnormal, headache, neutropenia. FLUDARABINE dosage: 240 MG. During the same period patient was treated with RITUXIMAB. Patient was hospitalized. Patient recovered.

FLUDARABINE problem was reported by a Health Professional from FRANCE on Aug 08, 2006. Female patient, 66 years of age, was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, cholestasis, cytolytic hepatitis, gamma-glutamyltransferase increased, jaundice, liver disorder. FLUDARABINE dosage: 40 MG/M2, INTRAVENOUS. During the same period patient was treated with NEURONTIN, MONICOR L, COKENZEN, LEVOTHYROXINE, PLAVIX, LANTUS. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported FLUDARABINE problem on Aug 28, 2006. Male patient, 58 years of age, was diagnosed with chronic lymphocytic leukaemia transformation and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: diabetic complication, hypertension, retinal haemorrhage. FLUDARABINE dosage: unknown. During the same period patient was treated with OXALIPLATIN, RITUXIMAB, CYTARABINE, LEVOFLOXACIN, SULFAMETHOXAZOLE, VORICONAZOLE, VALACYCLOVIR, HUMULIN. Patient was hospitalized. Patient recovered.

FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Sept 11, 2006. Female patient, weighting 124.3 lb, was diagnosed with stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: aggression, delirium. FLUDARABINE dosage: 42MG ONCE A DAY IV DRIP. During the same period patient was treated with CAMPATH, BUSULFAN, PROGRAF, PREVACID, REMERON, METOPROLOL, DAPSONE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported FLUDARABINE problem on Sept 14, 2006. Male patient, 60 years of age, weighting 190.7 lb, was diagnosed with myelodysplastic syndrome and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, dyspnoea, stem cell transplant. FLUDARABINE dosage: 71MG IV QD. During the same period patient was treated with CYTOXAN, CLOTRIMAZOLE, URSODIOL, FOLIC ACID, LANSOPRAZOLE, TAMSULOSIN, LEUKINE. Patient was hospitalized. Patient recovered.

FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Sept 18, 2006. Male patient, weighting 167.6 lb, was diagnosed with stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: bacterial infection, bk virus infection, blood creatinine increased, clostridial infection. FLUDARABINE dosage: unknown. During the same period patient was treated with CAMPATH, BUSULFAN, PROGRAF, LOVENOX, ORAL AND IV VANCOMYCIN, VORICONAZOLE, DAPTOMYCIN, CIFOFAVIR. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported FLUDARABINE problem on Sept 19, 2006. Female patient, 79 years of age, weighting 105.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: malignant melanoma. FLUDARABINE dosage: unknown. During the same period patient was treated with RITUXAN. Patient recovered.

FLUDARABINE problem was reported by a Health Professional from GERMANY on Sept 08, 2006. Female patient, 59 years of age, was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: catheter related infection, fall, graft versus host disease, proteus infection, retroperitoneal haematoma, syncope vasovagal, thrombosis. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported FLUDARABINE problem on Sept 20, 2006. Female patient, 68 years of age, weighting 156.5 lb, was diagnosed with chronic lymphocytic leukaemia, small cell carcinoma and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: coordination abnormal, dizziness, hypoaesthesia, neuropathy peripheral, nuclear magnetic resonance imaging abnormal, nystagmus, urinary tract infection. FLUDARABINE dosage: unknown. During the same period patient was treated with SYNTHROID, TYLENOL, KEFLEX, ACYLOVIR, PROTONIX, BENADRYL, PREDNISONE. Patient recovered.

FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Sept 25, 2006. Female patient, 66 years of age, weighting 322.3 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased. FLUDARABINE dosage: 44 MG X 3 DAYS IV. During the same period patient was treated with CYTOXAN. Patient recovered.

Health Professional from UNITED STATES reported FLUDARABINE problem on Sept 27, 2006. Male patient, 60 years of age, weighting 190.7 lb, was diagnosed with myelodysplastic syndrome and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: neutrophil count abnormal, platelet count abnormal, stem cell transplant, transplant failure. FLUDARABINE dosage: 71MG IV QD. During the same period patient was treated with CYTOXAN, UMBILICAL CORD BLOOD, NEUPOGEN, CYCLOSPORINE, MYCOPHENOLATE MOFETIL, ACYCLOVIR, CASPOFUNGIN. Patient was hospitalized. Patient recovered.

FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Sept 27, 2006. Female patient, weighting 141.1 lb, was diagnosed with stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: folliculitis, headache, rash. FLUDARABINE dosage: unknown. During the same period patient was treated with CAMPAT, MELPHALAN, PROGRAF, DIFLUCAN, ACYCLOVIR. Patient was hospitalized. Patient recovered.

Health Professional from AUSTRALIA reported FLUDARABINE problem on Sept 11, 2006. Male patient, 45 years of age, weighting 183.9 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: migraine. FLUDARABINE dosage: SEE IMGAE. During the same period patient was treated with CYCLOPHOSPHAMIDE, METOCLOPRAMIDE, CYCLIZINE, DOLASETRON, PANADENE. Patient was hospitalized. Patient recovered.

FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Aug 17, 2006. Male patient, 58 years of age, was diagnosed with chronic lymphocytic leukaemia transformation and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: hypertension, retinal detachment, retinal haemorrhage, retinal ischaemia. FLUDARABINE dosage: 30 MG/M2, DAYS 2-3. During the same period patient was treated with CYTARABINE, RITUXAN, OXALIPLATIN, COMPAZINE, DARVON, PROTONIX, HUMULIN, VALTREX. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported FLUDARABINE problem on Oct 11, 2006. Male patient, weighting 160.9 lb, was diagnosed with acute lymphocytic leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: back pain, blood culture positive, constipation, hepatic enzyme increased, infection, intervertebral discitis, osteomyelitis. FLUDARABINE dosage: 57MG DAILY IV. During the same period patient was treated with MELPHALAN, CAMPATH, PROGRAF, VALTREX, DILAUDID. Patient was hospitalized. Patient recovered.

FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Oct 11, 2006. Male patient, weighting 286.6 lb, was diagnosed with leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: chills, clostridial infection, diarrhoea, eosinophilia, graft versus host disease, nausea, pyrexia, rash. FLUDARABINE dosage: 72MG DAILY IV. During the same period patient was treated with MELPHALAN, CAMPATH, PREVACID, DIFLUCAN, VALTREX, PROGRAF, PRINIVOL, BACTIRM. Patient was hospitalized. Patient recovered.

Health Professional from RUSSIAN FEDERATION reported FLUDARABINE problem on Sept 28, 2006. Male patient, 75 years of age, weighting 167.6 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: acute sinusitis, adhesion, alanine aminotransferase increased, angiopathy, angiosclerosis, aortic arteriosclerosis, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased. FLUDARABINE dosage: 40 MG/M2, CYCLE X 5D, EVERY 28 D, ORAL. Patient was hospitalized. Patient recovered.

FLUDARABINE problem was reported by a Health Professional from GERMANY on Sept 29, 2006. Male patient, 80 years of age, weighting 152.1 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: anaemia, diarrhoea, insomnia, nausea, oedema peripheral, platelet count decreased, pleural effusion, pulmonary hypertension. FLUDARABINE dosage: unknown. Patient recovered.

Health Professional from GERMANY reported FLUDARABINE problem on Sept 29, 2006. Male patient, 73 years of age, weighting 218.3 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: anaemia, fatigue, leukopenia, renal failure. FLUDARABINE dosage: unknown. Patient recovered.

FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Nov 01, 2006. Female patient, weighting 121.0 lb, was diagnosed with haematopoietic stem cell mobilisation, stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: asthenia, blood test abnormal, fatigue, haematocrit decreased, haemoglobin decreased, platelet count decreased, white blood cell count decreased. FLUDARABINE dosage: 48 MG DAILY IV DRIP. During the same period patient was treated with CAMPATH, MELPHALAN. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported FLUDARABINE problem on Nov 01, 2006. Male patient, weighting 163.4 lb, was diagnosed with lymphoma and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: aspiration, blood culture positive, heart rate increased, infection, pharyngolaryngeal pain, productive cough, respiratory rate increased, sputum discoloured, staphylococcal infection. FLUDARABINE dosage: 57 MG DAILY IV. During the same period patient was treated with MELPHAAN, CAMPATH. Patient was hospitalized. Patient recovered.

FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Nov 08, 2006. Male patient, weighting 271.2 lb, was diagnosed with leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: bacterial infection, blood culture positive, deep vein thrombosis, dizziness, hypoxia, pulmonary embolism, syncope, unresponsive to stimuli. FLUDARABINE dosage: 72MG DAILY IV. During the same period patient was treated with MELPHLAN, CAMPAHT, PREDNISONE, PREVACID, VALTREX, DIFLUCAN. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported FLUDARABINE problem on Nov 08, 2006. Male patient, weighting 231.5 lb, was diagnosed with stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: culture urine positive, dysuria, pyrexia. FLUDARABINE dosage: 70MG ONCE A DAY IV DRIP. During the same period patient was treated with CAMPATH, MELPHALAN. Patient was hospitalized. Patient recovered.

FLUDARABINE problem was reported by a Physician from UNITED STATES on Oct 23, 2006. Male patient, 59 years of age, was diagnosed with stem cell transplant, prophylaxis against transplant rejection, immunosuppression and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, atrial fibrillation, blood stem cell transplant failure, cholangitis, fungal infection, gastrointestinal haemorrhage, hepatic encephalopathy. FLUDARABINE dosage: 30MG/M2 DAYS -4, -3, -2, INTRAVENOUS; SEE IMAGE. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient died on 10/18/2006.

Health Professional from GERMANY reported FLUDARABINE problem on Oct 23, 2006. Male patient, 73 years of age, weighting 218.3 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: anaemia, condition aggravated, fatigue, hepatomegaly, leukopenia, renal failure, splenomegaly. FLUDARABINE dosage: 25 MG/M2, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, METOPROLOL SUCCINATE, METFORMIN. Patient recovered.

FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Nov 14, 2006. Male patient, weighting 357.8 lb, was diagnosed with stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: culture urine positive. FLUDARABINE dosage: 70MG ONCE A DAY IV DRIP. During the same period patient was treated with CAMPATH, MELPHALAN, PEPCID, ALLOPURINOL, ZOCOR, VALTREX. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported FLUDARABINE problem on Nov 20, 2006. Female patient, 63 years of age, weighting 148.0 lb, was diagnosed with acute myeloid leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: anaemia, angina pectoris, chest discomfort, gastritis, oesophagitis. FLUDARABINE dosage: 24 MG OVER 30 MIN DAILY X 5DAYS IV. During the same period patient was treated with CARBOPLATIN, TOPOTECAN, THALIDOMIDE. Patient was hospitalized. Patient recovered.

FLUDARABINE problem was reported by a Pharmacist from UNITED STATES on Nov 22, 2006. Male patient, 63 years of age, weighting 330.7 lb, was diagnosed with bone marrow transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: amnesia, computerised tomogram abnormal, cough, lung infiltration, mental status changes, nervous system disorder, nuclear magnetic resonance imaging brain abnormal, oxygen saturation decreased. FLUDARABINE dosage: 68 MG DAILY X 4 DOSES IV. During the same period patient was treated with CAMPATH, LANTUS, FLUCONAZOLE, METOPROLOL SUCCINATE, DILTIAZEM, NEXIUM, ALLOPURINOL, TYLENOL. Patient recovered.

Health Professional from UNITED STATES reported FLUDARABINE problem on Nov 29, 2006. Male patient, weighting 163.1 lb, was diagnosed with non-hodgkin's lymphoma and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, cholelithiasis, constipation. FLUDARABINE dosage: 57MG DAILY IV. During the same period patient was treated with MELPHALAN, CAMPATH. Patient was hospitalized. Patient recovered.

FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Nov 29, 2006. Female patient, 63 years of age, weighting 148.0 lb, was diagnosed with acute myeloid leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: aplasia, blood albumin decreased, hypoglycaemia, platelet count decreased, white blood cell count decreased. FLUDARABINE dosage: 24 MG OVER 30 MIN PER DAY X 5D IV. During the same period patient was treated with CARBOPLATIN, TOPOTECAN, THALIDOMIDE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported FLUDARABINE problem on Nov 29, 2006. Male patient, weighting 141.1 lb, was diagnosed with stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: bacterial infection, blood culture positive, dysuria, pyrexia. FLUDARABINE dosage: 50MG ONCE A DAY IV DRIP. During the same period patient was treated with CAMPATH, BUSULFAN. Patient was hospitalized. Patient recovered.

FLUDARABINE problem was reported by a Physician from AUSTRALIA on Nov 10, 2006. Female patient, 40 years of age, was diagnosed with b-cell lymphoma and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, refractory anaemia with an excess of blasts. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient died.

Physician from AUSTRALIA reported FLUDARABINE problem on Nov 10, 2006. Female patient, 60 years of age, was diagnosed with waldenstrom's macroglobulinaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.

FLUDARABINE problem was reported by a Physician from AUSTRALIA on Nov 10, 2006. Male patient, 65 years of age, was diagnosed with b-cell lymphoma and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: lymphoma, malignant neoplasm progression, myelodysplastic syndrome. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient died.

Physician from AUSTRALIA reported FLUDARABINE problem on Nov 10, 2006. Female patient, 66 years of age, was diagnosed with b-cell lymphoma and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, neutropenic sepsis, pancytopenia. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXIMAB, MITOXANTRONE. Patient died.

FLUDARABINE problem was reported by a Physician from AUSTRALIA on Nov 10, 2006. Female patient, 53 years of age, was diagnosed with b-cell lymphoma and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE, CARMUSTINE, CYTARABINE, MELPHALAN. Patient recovered.

Physician from AUSTRALIA reported FLUDARABINE problem on Nov 10, 2006. Male patient, 53 years of age, was diagnosed with b-cell lymphoma and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, chronic myelomonocytic leukaemia, malignant neoplasm progression. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXIMAB, MITOXANTRONE. Patient died.

FLUDARABINE problem was reported by a Physician from AUSTRALIA on Nov 10, 2006. Male patient, 56 years of age, was diagnosed with waldenstrom's macroglobulinaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: chronic myelomonocytic leukaemia. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.

Physician from AUSTRALIA reported FLUDARABINE problem on Nov 10, 2006. Female patient, 66 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, refractory anaemia with an excess of blasts. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXIMAB. Patient died.

FLUDARABINE problem was reported by a Physician from AUSTRALIA on Nov 10, 2006. Female patient, 52 years of age, was diagnosed with b-cell lymphoma and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: disease progression, myelodysplastic syndrome, refractory anaemia with an excess of blasts. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXIMAB, MITOXANTRONE. Patient died.

Physician from AUSTRALIA reported FLUDARABINE problem on Nov 10, 2006. Male patient, 69 years of age, was diagnosed with follicle centre lymphoma, follicular grade i, ii, iii and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: lymphoma, malignant neoplasm progression, myelodysplastic syndrome. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXIMAB. Patient died.

FLUDARABINE problem was reported by a Physician from ITALY on Nov 23, 2006. Female patient was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, CHLORAMBUCIL. Patient recovered.

Physician from ITALY reported FLUDARABINE problem on Nov 23, 2006. Female patient was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, CHLORAMBUCIL. Patient recovered.

FLUDARABINE problem was reported by a Physician from ITALY on Nov 23, 2006. Female patient was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, CHLORAMBUCIL. Patient recovered.

Health Professional from UNITED STATES reported FLUDARABINE problem on Dec 20, 2006. Female patient, 63 years of age, weighting 148.0 lb, was diagnosed with acute myeloid leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: multi-organ failure, neutropenia, platelet count abnormal, white blood cell count decreased. FLUDARABINE dosage: 24 MG OVER 30 MIN. DAILY X 5 D IV. During the same period patient was treated with CARBOPLATIN, TOPOTECAN, THALIDOMIDE. Patient died on 12/15/2006.

FLUDARABINE problem was reported by a Physician from RUSSIAN FEDERATION on Dec 04, 2006. Female patient was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: cardiac failure acute, renal failure acute, tumour lysis syndrome. FLUDARABINE dosage: unknown. Patient died on 12/02/2006.

Physician from UNITED STATES reported FLUDARABINE problem on Oct 16, 2006. Female patient, 78 years of age, weighting 141.1 lb, was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, bilirubin conjugated increased, blood bilirubin increased, blood creatinine increased, blood glucose decreased, blood glucose increased, blood lactate dehydrogenase increased, bone marrow failure, cardiovascular insufficiency. FLUDARABINE dosage: unknown. Patient died on 10/14/2006.

FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Dec 15, 2006. Female patient, 53 years of age, weighting 185.2 lb, was diagnosed with antiviral prophylaxis and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: pericarditis, pyelonephritis acute. FLUDARABINE dosage: unknown. During the same period patient was treated with MABCAMPATH, COTRIM D, ACYCLOVIR. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported FLUDARABINE problem on Apr 11, 2007. Male patient, 72 years of age, was diagnosed with constipation, palliative care and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: ascites. FLUDARABINE dosage: 40 MG QD X 5. During the same period patient was treated with TRIMEBUTINE, FUROSEMIDE, LAEVOLAC EPS, PREDNISONE. Patient was hospitalized. Patient recovered.

FLUDARABINE problem was reported by a Health Professional from UNITED STATES on May 15, 2007. Male patient was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood potassium increased, blood urea increased, gallbladder disorder, haematocrit decreased, haemoglobin decreased, nausea, platelet count decreased. FLUDARABINE dosage: unknown. During the same period patient was treated with BUSULFAN, CAMPATH. Patient died on 05/11/2007.

Consumer or non-health professional from UNITED STATES reported FLUDARABINE problem on July 02, 2007. Male patient, weighting 147.0 lb, was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: bacteria sputum identified, herpes zoster, methicillin-resistant staphylococcal aureus test positive, urinary tract infection staphylococcal. FLUDARABINE dosage: 225 MG. During the same period patient was treated with RITUXIMAB. Patient was hospitalized. Patient recovered.

FLUDARABINE problem was reported by a Physician from UNITED KINGDOM on July 03, 2007. Female patient, 45 years of age, was diagnosed with stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: sarcoidosis. FLUDARABINE dosage: unknown. During the same period patient was treated with BUSULPHAN, PENICILLIN V, ACYCLOVIR, CAMPATH. Patient recovered.

Health Professional from UNITED STATES reported FLUDARABINE problem on July 10, 2007. Male patient, weighting 168.4 lb, was diagnosed with stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: gait disturbance, visual disturbance. FLUDARABINE dosage: 53MG DAILY IV DRIP. During the same period patient was treated with CAMPATH, BUSULFAN, PORGRAF, ACTIGALL, DIFLUCAN, VALTREX, BACTRIM. Patient was hospitalized. Patient recovered.

FLUDARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 13, 2007. Male patient, weighting 183.0 lb, was diagnosed with acute myeloid leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: hypoxia, pulmonary embolism, pyrexia. FLUDARABINE dosage: unknown. During the same period patient was treated with MELPHALAN, CAMPATH. Patient recovered.

Physician from UNITED KINGDOM reported FLUDARABINE problem on July 12, 2007. Male patient was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: petit mal epilepsy. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.

FLUDARABINE problem was reported by a Pharmacist from UNITED STATES on July 17, 2007. Male patient, 45 years of age, weighting 152.3 lb, was diagnosed with bone marrow transplant, myelofibrosis and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: brain natriuretic peptide increased, cardiac failure congestive, ejection fraction decreased. FLUDARABINE dosage: 60MG INFUSED OVER 30 MI IV. During the same period patient was treated with FLUDARABINE PHOSPHATE, MELPHALAN. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported FLUDARABINE problem on July 18, 2007. Male patient, 72 years of age, weighting 121.3 lb, was diagnosed with constipation, palliative care and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: neoplasm malignant. FLUDARABINE dosage: 40 MG QD X 5. During the same period patient was treated with TRIMEBUTINE, FUROSEMIDE, LAEVOLAC EPS, PREDNISONE, FENTANYL TRANSDERMAL SYSTEM, OXALIPLATIN. Patient was hospitalized. Patient recovered.

FLUDARABINE problem was reported by a Health Professional from UNITED STATES on July 31, 2007. Female patient, weighting 120.6 lb, was diagnosed with bone marrow conditioning regimen, stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: cryptogenic organising pneumonia. FLUDARABINE dosage: 54 MG DAILY IV DRIP. During the same period patient was treated with FLUDARABINE PHOSPHATE, THIOTEPA. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported FLUDARABINE problem on Aug 07, 2007. Female patient, weighting 133.2 lb, was diagnosed with stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: hypotension, ill-defined disorder, pyrexia. FLUDARABINE dosage: 54MG DAILY IV DRIP. During the same period patient was treated with CAMPATH, MELPHALAN. Patient was hospitalized. Patient recovered.

FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Aug 07, 2007. Female patient was diagnosed with stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: cryptogenic organising pneumonia, fatigue. FLUDARABINE dosage: 54 MG DAILY IV DRIP. During the same period patient was treated with THIOTEPA. Patient died on 08/02/2007.

Physician from UNITED STATES reported FLUDARABINE problem on Aug 07, 2007. Male patient, 72 years of age, weighting 121.3 lb, was diagnosed with constipation, palliative care and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: neoplasm malignant. FLUDARABINE dosage: 40 MG QD X 5. During the same period patient was treated with TRIMEBUTINE, FUROSEMIDE, LAEVOLAC EPS, PREDNISONE, FENTANYL, OXALIPLATIN. Patient was hospitalized. Patient died on 07/26/2007.

FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Aug 15, 2007. Male patient was diagnosed with stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: blood culture positive, jc virus infection, progressive multifocal leukoencephalopathy. FLUDARABINE dosage: 53 MG DAILY IV DRIP. During the same period patient was treated with CAMPATH, BUSULFAN. Patient died on 08/11/2007.

Health Professional from UNITED KINGDOM reported FLUDARABINE problem on May 21, 2007. Male patient, weighting 192.9 lb, was diagnosed with b-cell lymphoma and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: ascites, constipation, deep vein thrombosis, febrile neutropenia, intestinal obstruction, white blood cell count decreased. FLUDARABINE dosage: unknown. During the same period patient was treated with NOVANTRONE, ALLOPURINOL, DEXAMETHASONE, PARACETAMOL, SPIRONOLACTONE, SULFAMETHOXAZOLE. Patient recovered.

FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Aug 22, 2007. Female patient, weighting 159.8 lb, was diagnosed with stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: blood culture positive, escherichia infection, hypotension, infusion related reaction, pyrexia, stem cell transplant, tachycardia. FLUDARABINE dosage: 50 MG DAILY IV DRIP. During the same period patient was treated with THIOTEPA. Patient was hospitalized. Patient recovered.

Health Professional from RUSSIAN FEDERATION reported FLUDARABINE problem on Aug 17, 2007. Male patient, 55 years of age, weighting 143.3 lb, was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage, thrombocytopenia. FLUDARABINE dosage: 42.5 MG, 1X/DAY. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient died on 12/30/2006.

FLUDARABINE problem was reported by a Physician from UNITED KINGDOM on Aug 10, 2007. Female patient was diagnosed with chronic lymphocytic leukaemia, prophylaxis and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: coronary artery thrombosis. FLUDARABINE dosage: 25 MG/M2, 1X/DAY. During the same period patient was treated with COTRIM, CYCLOPHOSPHAMIDE. Patient died.

Physician from AUSTRIA reported FLUDARABINE problem on Aug 22, 2007. Male patient was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: pemphigus. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXIMAB. Patient was hospitalized. Patient recovered.

FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Aug 22, 2007. Female patient, 73 years of age, was treated with FLUDARABINE. FLUDARABINE dosage: unknown. During the same period patient was treated with CAMPATH. Patient died on 04/28/2007.

Physician from AUSTRIA reported FLUDARABINE problem on Aug 24, 2007. Male patient was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: pemphigus. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXIMAB. Patient recovered.

FLUDARABINE problem was reported by a Physician from UNITED STATES on Aug 24, 2007. Female patient, 53 years of age, weighting 185.2 lb, was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: pericardial effusion. FLUDARABINE dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CAMPATH, COTRIM. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported FLUDARABINE problem on Sept 04, 2007. Male patient, 68 years of age, weighting 243.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: blood culture positive, bone marrow failure, fungal infection, hypoacusis, mental status changes, myalgia, pancytopenia, respiratory distress. FLUDARABINE dosage: 60MG QD X 3;Q28D IV. Patient was hospitalized. Patient died on 08/05/2007.

Showing 1-75 of 160 Next >

Ask Our Patient Community about FLUDARABINE

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
Minirin